Affinity Healthcare Fund and Affinity Asset Advisors' Ownership in iBio, Inc.

Affinity Healthcare Fund, LP and Affinity Asset Advisors, LLC have filed a Schedule 13G indicating their ownership of 9.99% of iBio, Inc.'s common stock. The filing, dated August 26, 2025, reveals that the Fund beneficially owns 4,280,000 shares of Common Stock, issuable upon exercise of warrants, subject to a beneficial ownership limitation of 9.99%. Affinity Asset Advisors, LLC, as the investment manager of the Fund, exercises investment discretion over these securities. Both entities share voting and dispositive power over the shares. The filing also includes certifications that the securities were not acquired for the purpose of influencing the control of the issuer.